ERBB2 targeting agents
3 abstracts
Abstract
Retrospective analysis of genetically matched therapies in salivary gland cancer entities using a real-world database in a tertiary salivary gland cancer expertise center.Org: Department of Medical Oncology, Radboud University Medical Center, Nijmegen, Netherlands, Department for Health Evidence, Radboud University Medical Center, Nijmegen, Netherlands, Department of Urology, Radboud University Medical Center, Nijmegen, Netherlands, Radboud University Medical Center, Nijmegen, Netherlands, Department of Pathology, Radboud University Medical Center, Nijmegen, Netherlands,
Abstract
Differences of RAS/BRAF mutations between ISCC and RSCC in a Chinese population.Org: the General Hospital of Southern Theater Command，PLA., Guangzhou, China, AcornMed Biotechnology Co., Ltd., Beijing, China,
Abstract
Distinguishing primary mucinous ovarian tumors from metastases of non-gynecologic mucinous cancers: Can we leverage next-generation sequencing?Org: Weill Cornell Medicine - Qatar, Doha, Qatar, Qatar, Weill Cornell Medicine and NewYork-Presbyterian Hospital, New York, NY, New York Oncology Hematology PC,